Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/45397
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGaneshpurkar, Aditya-
dc.contributor.authorSaluja, Ajay-
dc.date.accessioned2018-11-12T08:42:47Z-
dc.date.available2018-11-12T08:42:47Z-
dc.date.issued2018-10-
dc.identifier.issn0975-0967 (Online); 0972-5849 (Print)-
dc.identifier.urihttp://nopr.niscair.res.in/handle/123456789/45397-
dc.description626-631en_US
dc.description.abstractThe use of plant products as immunomodulator has a long history. For eternal era, plant, mineral and animal products are used as drugs for the treatment of various diseases. The present-day synthetic compounds find their leads in natural products. The process of immunomodulation amends the immune system of an individual by prying with its usual functions. Research of immunomodulators from natural sources has been extensively studied for modulation of immune system along with protection and prevention of diseases. Catechin, a flavonoid has been investigated for its potential anti-inflammatory effects. Analgesic effects have been observed for catechin in experimental animals. The present study is focused on exploring the in silico interaction of catechin with some chemokines and inflammatory targets. In this study, catechin was docked with tumour necrosis factor alpha (TNF-α), interleukin (IL)-1β, IL-6, inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX-2). Docking studies revealed the interaction of catechin with these targets. The result of present study provides insight for the discovery of novel molecules for immunomodulation and treatment of inflammatory disorders. Findings from the present study show that catechin interact with several chemokines and inflammatory mediators. Further studies quantitative structure activity relationship and quantitative structure property relationship on catechin and associated flavonoids are necessary to develop and establish studies which may serve a stepping stone for the development of novel and safe immunomodulator. Catechin, can, therefore, can be considered as a candidate for development of an immunomodulatory agent.en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJBT Vol.17(4) [October 2018]en_US
dc.subjectCatechinen_US
dc.subjectImmunomodulatory agenten_US
dc.subjectInflammationen_US
dc.subjectCytokinesen_US
dc.subjectNitric oxideen_US
dc.titleIn silico interaction of catechin with some immunomodulatory targets: A docking analysisen_US
dc.typeArticleen_US
Appears in Collections:IJBT Vol.17(4) [October 2018]

Files in This Item:
File Description SizeFormat 
IJBT 17(4) 626-631.pdf243.57 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.